Viewing Study NCT06322667


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2025-12-28 @ 4:07 AM
Study NCT ID: NCT06322667
Status: RECRUITING
Last Update Posted: 2025-02-18
First Post: 2024-03-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab
Sponsor: Eisai Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module